Eczema Relief

ARSENICUM IODATUM, KALI BROMATUM, KALI MURIATICUM, NATRUM BROMATUM, NICCOLUM SULPHURICUM, SULPHUR IODATUM, VIOLA TRICOLOR, ZINCUM BROMATUM. ORAL HUMAN OTC DRUG

Eczema Relief is an FDA drug label for the active ingredient ARSENICUM IODATUM, KALI BROMATUM, KALI MURIATICUM, NATRUM BROMATUM, NICCOLUM SULPHURICUM, SULPHUR IODATUM, VIOLA TRICOLOR, ZINCUM BROMATUM. manufactured by OHM PHARMA INC. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20211229.

Generic name
ARSENICUM IODATUM, KALI BROMATUM, KALI MURIATICUM, NATRUM BROMATUM, NICCOLUM SULPHURICUM, SULPHUR IODATUM, VIOLA TRICOLOR, ZINCUM BROMATUM.
Manufacturer
OHM PHARMA INC.
Product type
HUMAN OTC DRUG
Route
ORAL
Dosage form
N/A
NDC
66096-192
Application
N/A
Label effective
20211229

Active ingredients

ACTIVE INGREDIENTS (HPUS*): Equal amounts of : Arsenicum Iodatum 8X, Kali Bromatum 4X, Kali Muriaticum 4X, Natrum Bromatum 4X, Niccolum Sulphuricum 5X, Sulphur Iodatum 14X, Viola Tricolor 12X, Zincum Bromatum 6X. * ​The letters "HPUS" indicate that the components in this product are officially monographed in the Homeopathic Pharmacopeia of the United States.

Indications & Usage

USES: Temporarily relieves eczema - psoriatic skin symptoms.** ​**This statement has not been evaluated by the FDA. It is based on documented Homeopathic Materia Medica.

Dosage & Administration

DIRECTIONS: Shake 10 times before use. Adults & children above 12 years of age: spray 3-4 times under the tongue 2-3 times a day, or as directed by a health care professional. Children under 12: use half the adult dose.

Contraindications

Not available.

Warnings

WARNINGS: IF PREGNANT OR BREAST-FEEDING, ask a health care professional before use. If symptoms worsen or persist for more than a week, discontinue use and contact a doctor. ​KEEP OUT OF REACH OF CHILDREN.

Adverse Reactions

Not available.